TNKS
| Official symbol: | TNKS |
| Full name: | tankyrase |
| Location: | 8p23.1 |
| Also known as: | PARP5A, TINF1, PARP-5a, TNKS1, TIN1, pART5 |
| Entrez ID: | 8658 |
| Ensembl ID: | ENSG00000173273 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.50 |
|
|
|
| Recurrently deleted in 3 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 5 |
|
|
| Fusions detected in 4 cancer type(s) |
|
| |
|
|
|
| Functional class: | Enzyme |
| JensenLab PubMed score: | 116.38 (Percentile rank: 74.86%) |
| PubTator score: | 574.49 (Percentile rank: 94.13%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
